Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PLSH | Common Stock | Award | +16.8M | 16.8M | Jun 30, 2021 | Direct | F1 | |||
transaction | PLSH | Common Stock | Award | +318M | 318M | Jun 30, 2021 | Held by Quintel-MC, Incorporated | F1 | |||
transaction | PLSH | Series C Preferred Stock | Award | +1M | 1M | Jun 30, 2021 | Held by Quintel-MC, Incorporated | F2 | |||
transaction | PLSH | Series C-1 Preferred Stock | Award | +10K | 10K | Jun 30, 2021 | Held by Quintel-MC, Incorporated | F2 | |||
transaction | PLSH | Series D Preferred Stock | Award | +10K | 10K | Jun 30, 2021 | Held by J&N Real Estate Company LLC | F2 |
Id | Content |
---|---|
F1 | The shares of common stock were acquired in exchange for shares of common stock of Panacea Life Sciences, Inc. ("Panacea"), in connection with the Securities Exchange Agreement dated June 30, 2021 between the Issuer, Panacea and the shareholders of Panacea (the "Exchange Agreement"). |
F2 | The shares of preferred stock were acquired in exchange for shares of preferred stock of Panacea, in connection with the Exchange Agreement. |